Skip to content
About Us
Our Science
Our Science
Therapeutic Hypothesis
Literature Support
Our Publications
Our Programs
Our Team
News
Contact
Menu
About Us
Our Science
Our Science
Therapeutic Hypothesis
Literature Support
Our Publications
Our Programs
Our Team
News
Contact
Twitter
Linkedin-in
News
EXCITING NEWS
Featured Articles
February 9, 2021
The McQuade Center for Strategic Research and Development and Eikonizo Therapeutics Enter Agreement to Develop Treatments for Patients with Rare Diseases
August 12, 2020
Meet the 21 biotech startups that top VCs say are poised to take off in the next 12 months
(Subscription Required)
July 08, 2020
Eikonizo Therapeutics Announces Publication of the First-in-Human Study of [18F]EKZ-001 and Expansion of Leadership Team, Adding Extensive Experience in Preclinical and Clinical Development
February 9, 2021
The McQuade Center for Strategic Research and Development and Eikonizo Therapeutics Enter Agreement to Develop Treatments for Patients with Rare Diseases
August 12, 2020
Meet the 21 biotech startups that top VCs say are poised to take off in the next 12 months
(Subscription Required)
July 08, 2020
Eikonizo Therapeutics Announces Publication of the First-in-Human Study of [18F]EKZ-001 and Expansion of Leadership Team, Adding Extensive Experience in Preclinical and Clinical Development
June 25, 2020
Episode 59: Using Tau to Target Alzheimer’s
June 25, 2020
Episode 59: Using Tau to Target Alzheimer’s
June 2, 2020
UNDER THE MICROSCOPE: LUDO VAN DEN BOSCH ON RETURNING TO WORK, EXPLORING THERAPEUTIC STRATEGIES TO BATTLE ALS & FTD
May 5, 2020
TARGET ALS AND AFTD ANNOUNCE $5MM IN GRANTS FOR RESEARCH TARGETING TREATMENTS AND BIOMARKERS
June 2, 2020
UNDER THE MICROSCOPE: LUDO VAN DEN BOSCH ON RETURNING TO WORK, EXPLORING THERAPEUTIC STRATEGIES TO BATTLE ALS & FTD
May 5, 2020
TARGET ALS AND AFTD ANNOUNCE $5MM IN GRANTS FOR RESEARCH TARGETING TREATMENTS AND BIOMARKERS
April 1, 2020
Making Progress On A Micro-Budget
April 1, 2020
Making Progress On A Micro-Budget
Earlier Articles
March 20, 2020
Eikonizo: brain-penetrant HDAC inhibitors for neurodegeneration
(Subscription Required)
March 10, 2020
Women of the C-Suite: “Your career path might not always be linear,” With Janice Kranz, PhD of Eikonizo Therapeutics
March 4, 2020
Nearly $4 Million In Research Funding For Promising New Treatments In Alzheimer's And Other Dementia
March 20, 2020
Eikonizo: brain-penetrant HDAC inhibitors for neurodegeneration
(Subscription Required)
March 10, 2020
Women of the C-Suite: “Your career path might not always be linear,” With Janice Kranz, PhD of Eikonizo Therapeutics
March 4, 2020
Nearly $4 Million In Research Funding For Promising New Treatments In Alzheimer's And Other Dementia
December 30, 2019
Mass. Biotech Sector Feels Drug Pricing Pressure
December 30, 2019
Mass. Biotech Sector Feels Drug Pricing Pressure
December 9, 2019
Untangling tau protein
(Subscription Required)
October 23, 2019
New Approaches to Alzheimer’s and Tauopathies: Eikonizo Therapeutics
December 9, 2019
Untangling tau protein
(Subscription Required)
October 23, 2019
New Approaches to Alzheimer’s and Tauopathies: Eikonizo Therapeutics
September 24, 2019
Dementia-Treatment Startup Seeks to Overcome Prior Drugs’ Failures
(Subscription Required)
September 24, 2019
Dementia-Treatment Startup Seeks to Overcome Prior Drugs’ Failures
(Subscription Required)